Shandong Lukang Pharmaceutical Co., Ltd.SSE: 600789

Announcement on Obtaining Approval for Marketing of Chemical API Aprepitant

· Issued by Shandong Lukang Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Shandong Lukang Pharmaceutical Co., Ltd. announced the approval for marketing its chemical API Aprepitant, as detailed in the filing.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining Approval for Marketing of Chemical API Aprepitant

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shandong Lukang Pharmaceutical Co., Ltd. on 6ix

Earlier from Shandong Lukang Pharmaceutical

Later from Shandong Lukang Pharmaceutical

All Shandong Lukang Pharmaceutical news releases